OphSourceHomeJournal CollectionOphSource ShopEvents
Journal Home
Search for

Volume 113, Issue 2, Pages 333-337 (February 2006)


View previous. 24 of 41 View next.

Compressive Optic Neuropathy after Use of Oxidized Regenerated Cellulose in Orbital Surgery: Review of Complications, Prophylaxis, and Treatment

Presented as a poster at: Joint Meeting of the American Academy of Ophthalmology and European Society of Ophthalmology, October 23–26, 2004; New Orleans, Louisiana, and American Society of Ophthalmic Plastic and Reconstructive Surgery 35th Annual Scientific Symposium, October 22–23, 2004; New Orleans, Louisiana.

Yonca Ozkan Arat, MD1Corresponding Author Information, E. Ulysses Dorotheo, MD2, Rosa A. Tang, MD, MPH2, Milton Boniuk, MD1, Jade S. Schiffman, MD23

Received 19 April 2005; accepted 1 November 2005. published online 09 January 2006.

Purpose

We report 2 cases of compressive optic neuropathy after use of oxidized regenerated cellulose (ORC) in orbital surgery. To our knowledge, no complications have been reported previously after use of this material in orbital surgery. We also review the complications related to its retention at operative sites outside the orbit and recommend precautions to avoid them.

Design

Retrospective interventional case reports.

Participants

Two patients with compressive optic neuropathy after use of ORC in orbital surgery.

Methods

Case reports from 2 different clinics and review of the English scientific literature.

Main Outcome Measures

Best-corrected visual acuity, extraocular motility, proptosis, and chemosis.

Results

One patient underwent orbital exploration and biopsy of an orbital tumor, and the second had repair of an orbital floor fracture. Postoperatively, both presented with chemosis, ophthalmoplegia, and progressive loss of vision. Orbital imaging revealed a retrobulbar soft-tissue density compatible with hematoma. Repeat orbital exploration revealed the soft-tissue mass to be swollen ORC.

Conclusions

Retained intraorbital ORC may cause a compartment syndrome and should be suspected in postoperative patients with orbital symptoms. When ORC is used around the optic nerve, it should be removed after hemostasis is achieved.

1 Baylor College of Medicine, Houston, Texas.

2 University of Texas Medical Branch, Galveston, Texas.

3 University of Houston Eye Institute, Houston, Texas.

Corresponding Author InformationCorrespondence to Yonca Ozkan Arat, MD, 2222 Maroneal #342, Houston, TX 77030.

 Manuscript no. 2005-326.

The authors have no financial interest in and had no financial support related to the article.

PII: S0161-6420(05)01299-6

doi:10.1016/j.ophtha.2005.11.003


View previous. 24 of 41 View next.